Acute cor pulmonale - current complications of cystic fibrosis

2021 ◽  
Vol 22 (1) ◽  
pp. 62-66
Author(s):  
Marcela Kreslová ◽  
Adéla Skalická ◽  
Veronika Schwarzová ◽  
Zuzana Horková ◽  
Jiří Bejček ◽  
...  
2014 ◽  
Vol 66 (5) ◽  
pp. 543-545
Author(s):  
Sandeep Mohanan ◽  
C.G. Sajeev ◽  
Kader Muneer ◽  
G. Rajesh ◽  
M.N. Krishnan ◽  
...  

1984 ◽  
pp. 285-324 ◽  
Author(s):  
Warren R. Summer

2022 ◽  
Vol 12 ◽  
Author(s):  
Matthieu Petit ◽  
Edouard Jullien ◽  
Antoine Vieillard-Baron

Acute respiratory distress syndrome (ARDS) is characterized by protein-rich alveolar edema, reduced lung compliance and severe hypoxemia. Despite some evidence of improvements in mortality over recent decades, ARDS remains a major public health problem with 30% 28-day mortality in recent cohorts. Pulmonary vascular dysfunction is one of the pivot points of the pathophysiology of ARDS, resulting in a certain degree of pulmonary hypertension, higher levels of which are associated with morbidity and mortality. Pulmonary hypertension develops as a result of endothelial dysfunction, pulmonary vascular occlusion, increased vascular tone, extrinsic vessel occlusion, and vascular remodeling. This increase in right ventricular (RV) afterload causes uncoupling between the pulmonary circulation and RV function. Without any contractile reserve, the right ventricle has no adaptive reserve mechanism other than dilatation, which is responsible for left ventricular compression, leading to circulatory failure and worsening of oxygen delivery. This state, also called severe acute cor pulmonale (ACP), is responsible for excess mortality. Strategies designed to protect the pulmonary circulation and the right ventricle in ARDS should be the cornerstones of the care and support of patients with the severest disease, in order to improve prognosis, pending stronger evidence. Acute cor pulmonale is associated with higher driving pressure (≥18 cmH2O), hypercapnia (PaCO2 ≥ 48 mmHg), and hypoxemia (PaO2/FiO2 < 150 mmHg). RV protection should focus on these three preventable factors identified in the last decade. Prone positioning, the setting of positive end-expiratory pressure, and inhaled nitric oxide (INO) can also unload the right ventricle, restore better coupling between the right ventricle and the pulmonary circulation, and correct circulatory failure. When all these strategies are insufficient, extracorporeal membrane oxygenation (ECMO), which improves decarboxylation and oxygenation and enables ultra-protective ventilation by decreasing driving pressure, should be discussed in seeking better control of RV afterload. This review reports the pathophysiology of pulmonary hypertension in ARDS, describes right heart function, and proposes an RV protective approach, ranging from ventilatory settings and prone positioning to INO and selection of patients potentially eligible for veno-venous extracorporeal membrane oxygenation (VV ECMO).


2002 ◽  
Vol 14 (7) ◽  
pp. 775-777 ◽  
Author(s):  
Alfonso Gutiérrez-Macías ◽  
Kepa Elorriaga Barandiarán ◽  
Francisco J. Bilbao Ercoreca ◽  
Mikel Martínez-Ortíz de Zárate

ASAIO Journal ◽  
2018 ◽  
Vol 64 (6) ◽  
pp. e187-e190 ◽  
Author(s):  
Erik R. Dong ◽  
David G. Ng ◽  
Danny Ramzy ◽  
Joshua S. Chung ◽  
Oren Friedman ◽  
...  

PEDIATRICS ◽  
1982 ◽  
Vol 70 (5) ◽  
pp. 728-741
Author(s):  
Arthur J. Moss

Available evidence indicates that cystic fibrosis causes widespread involvement of the cardiovascular system. Aside from the heart, unusual aberrations have been observed in the bronchial arteries, the aorta, and the systemic capillaries. Of all cardiovascular complications, cor pulmonale is the most serious. Recognition of a significant degree of cor pulmonale is generally possible on the basis of the severity of the underlying disease. Although echocardiography and radionucide angiography are valuable research tools in the study of cor pulmonale in cystic fibrosis, they add little, from a practical standpoint, to the management of the patient. The basis of cor pulmonale is hypoxemia and unless this is relieved, no enduring effect can be expected from therapy directed toward the heart. Inasmuch as cystic fibrosis is a progressive disease, cor pulmonale is also progressive. At best, cardiac treatment represents a delaying action that may provide more time to combat an intercurrent infection.


PEDIATRICS ◽  
1977 ◽  
Vol 59 (4) ◽  
pp. 588-594
Author(s):  
Amnon Rosenthal ◽  
Lawrence N. Button ◽  
Kon Taik Khaw

Simultaneous red blood cell (RBC) and plasma volume determinations were obtained in 16 patients with cystic fibrosis (CF) and moderately severe pulmonary involvement. Hypervolemia with an increase in both RBC and plasma volumes was observed. Changes in blood volume were marked when values were indexed by weight but less significant when indexed by height. Decreasing systemic arterial oxygen saturation was associated with a progressive increase in RBC mass, hematocrit value, and hemoglobin level and a decrease in mean corpuscular hemoglobin concentration. RBC and total blood volumes were highest in patients with cor pulmonale and congestive heart failure. However, the compensatory polycythemic response in patients with CF was inadequate when compared with the response to hypoxemia in patients with cyanotic congenital heart disease. The insufficient oxygen-carrying capacity may compromise tissue oxygen delivery and necessitate treatment.


Sign in / Sign up

Export Citation Format

Share Document